Compare Rent the Runway Inc (RENT) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rent the Runway Inc vs ResMed Inc. — how do they compare? Rent the Runway Inc trades at $1.73 (market cap $61.75M), while ResMed Inc. trades at $230.22 (market cap $31.89B). The key difference: ResMed Inc. is far larger — about 516.4× Rent the Runway Inc's market cap, and ResMed Inc. pays a 1.16% dividend while Rent the Runway Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rent the Runway Inc for 56 Days and ResMed Inc. for 51 Days on average.
| RENT | RMD | |
|---|---|---|
Market Cap | $61.75M | $31.89B |
Volume | 193,323 | 618,314 |
Sector | Consumer Cyclical | Health |
52-Week High | $9.39 | $277.88 |
52-Week Low | $1.55 | $182.82 |
Typical Hold Time | 56 Days | 51 Days |
Enterprise Value | $228.75M | $31.24B |
Dividend Yield | — | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rent the Runway (RENT) trades at $1.68, up 1.82% on the day, amid a bearish technical signal. The company reported revenue of $306.20M in 2025 with a net loss of $69.90M, though losses are narrowing year-over-year. Recent news includes a CEO appointment and multiple law firm investigations into investor claims, creating mixed sentiment.
The outlook is cautious; while revenue growth and margin improvements are positive, negative shareholder equity and high debt levels pose significant risks. Analyst consensus is mixed with 42% buy ratings, but legal overhangs and profitability challenges temper near-term optimism.
ResMed (RMD) trades at $228.37, up 1.06% today, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15B in 2025, with a robust net income margin of 26.94%. Recent news highlights management's presentation at the Morgan Stanley Healthcare Conference and an upcoming Q1 2027 earnings report.
The outlook is positive, supported by earnings growth targets of 12-14% and a consensus price target of $242.70. Key risks include competitive pressures and ongoing legal investigations. Institutional buying activity and analyst upgrades reflect confidence, but investors should monitor execution against growth targets and any developments from the legal probe.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rent the Runway Inc
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
